Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spiriva in COPD (UPLIFT)
NCT00144339Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Dec 2002
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 37
01
Overview
A Phase 3 trial of tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Dec 2002; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00144339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00144339.